Report Outlook
Market Size | CAGR | Dominating Region |
---|---|---|
USD 270.01 Billion By 2029 | 6.9% | North America |
By Business Mode | By Synthesis Type | By Type | By Application |
---|---|---|---|
|
|
|
|
SCOPE OF THE REPORT
Active Pharmaceutical Ingredient/ API Market Overview
The global active pharmaceutical ingredient/ API market is projected to reach USD 270.01 billion by 2029 from USD 160.36 billion in 2020, at a CAGR of 6.9 % from 2022 to 2029.
Active Pharmaceutical Ingredient (API) is the primary component in the manufacturing of pharmaceutical drugs that provides the desired therapeutic effect. APIs can be either synthetic or naturally derived and can be small molecules, proteins, peptides, or nucleic acids. They are responsible for treating or preventing specific medical conditions and are used in various drug formulations. The quality, purity, and safety of APIs are crucial factors in the production of safe and effective drugs002E
APIs are produced through complex chemical processes that involve multiple steps, including synthesis, extraction, and purification. The process of producing APIs must meet strict quality control measures, and it is subject to stringent regulatory requirements to ensure that the final product is safe and effective for human use. APIs can be derived from natural sources, such as plants, animals, or microorganisms, or they can be synthetically produced in a laboratory. They can be small molecules, peptides, proteins, or nucleic acids, depending on the intended therapeutic use.
The rising demand for generic medications is one of the primary reasons. The rising frequency of chronic illnesses, along with rising healthcare expenses, has increased demand for low-cost medicines. APIs are critical components in the creation of generic pharmaceuticals, which are a less expensive alternative to branded treatments. Technology advances are another driver of the API industry. Synthetic biology, gene editing, and bioprocessing advancements have resulted in the development of novel APIs with enhanced effectiveness and safety profiles.
The high cost of research and development (R&D) developing new APIs is one of the key constraints. Developing new APIs necessitates substantial expenditure in research and clinical trials, and bringing a novel API to market might take years. This high R&D expenditure may hinder new market entrants and raise manufacturing costs for existing market entrants. The rising regulatory requirements for API production are another constraint in the API business. To assure the quality, safety, and efficacy of APIs, regulators across the world have adopted tougher requirements for their manufacturing, testing, and approval. Compliance with these rules can be time-consuming and expensive for API makers, thereby increasing manufacturing costs and limiting the availability of particular APIs.
The growing desire for personalized treatment is one of the key opportunities. Personalized medicine is the practice of personalizing medicines to individual patients based on genetic composition, lifestyle, and other characteristics. APIs are critical in the development of personalized medicine, and the API industry is predicted to grow considerably as the need for personalized therapies rises. The increased emphasis on biologics is another possibility in the API business. Biologics are complex compounds created by living organisms that are used to treat a variety of ailments such as cancer, autoimmune disorders, and infectious diseases.
ATTRIBUTE | DETAILS |
Study period | 2022-2029 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2029 |
Historical period | 2018-2022 |
Unit | Value (USD Billion) Volume (Kilotons) |
Segmentation | By Business Mode, By Synthesis Type, By Type, By Application, By Region |
By Business Mode |
|
By Synthesis Type |
|
By Type |
|
By Application |
|
By Region |
|
Active Pharmaceutical Ingredient/ API Market Segment Analysis
The global active pharmaceutical ingredient/ API market is segmented by business mode, synthesis type, type, application and region.
Based on business mode, the market is divided into captive API, merchant API. The captive API category is the market’s largest contributor and is predicted to increase at a CAGR of 6.15% during the forecast period. The captive API component of the study includes of APIs utilized by pharmaceutical companies to create completed dosage forms on-site. APIs have historically been manufactured in the home countries of pharmaceutical corporations. To cut expenses, several corporations have recently resorted to outsource manufacturing. As a result, stronger restrictions and inspections have been put in place, dramatically altering the way these pharmaceuticals are governed. decline global economic development, greater pricing pressure from cost-cutting measures implemented by most countries, and rising competition from generic medications are all factors contributing to the market’s decline.
Based on synthesis type, the market is classified into synthetic, biotech. The synthetic category accounts for the majority of the market and is predicted to grow at a CAGR of 5.70% during the forecast period. Active pharmaceutical substances are classified into two types based on their origin: synthetic chemical medications and natural chemical pharmaceuticals. Chemically synthesized chemicals are classified into two types: inorganic synthetic drugs and organic synthetic medications. Inorganic synthetic pharmaceuticals include inorganic substances such as magnesium trisilicate and aluminium hydroxide.
Based on type, the market is bifurcated into generic, branded. Branded APIs, which have traditionally been the largest category, are nevertheless increasing more slowly than generic APIs, which are the fastest-growing. The need for branded APIs has declined dramatically over time as the pharmaceutical business has consolidated and some well-known trademarks have gone off-patent. Generic APIs have witnessed a boom and are expected to continue rising gradually as more patents expire and generic production facilities increase internationally. Several hundred businesses manufacture APIs for innovative medications and generic pharmaceuticals, resulting in a highly fragmented industry.
Based on application, the market is segmented into cardiology, pulmonology, oncology, ophthalmology, neurology, orthopedic. The oncology segment is currently the largest in the API market. This is due to the high demand for cancer treatments and the increasing use of targeted therapies and biologics in cancer treatment. Additionally, the rise in the incidence of cancer worldwide has driven the growth of the oncology API market. The cardiology and pulmonology segments also hold a significant share of the API market. The high prevalence of cardiovascular and respiratory diseases, particularly in aging populations, has driven the demand for APIs in these therapeutic areas.
Active Pharmaceutical Ingredient/ API Market Players
The global active pharmaceutical ingredient/ API market key players include Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., AbbVie Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Amgen Inc.
Industry Development:
- 13, 2023: Eli Lilly and Company will supply its active pharmaceutical ingredient (API) for human insulin at a reduced price to International Agencies (Bangladesh) Ltd. (IABL) in an effort to increase patient access and improve affordability for high-quality insulin for nearly one million people living with diabetes in Bangladesh by 2030.
- June 06, 2022: Pfizer Inc. (NYSE: PFE) announced that it will increase its commitment to US manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling US-based production of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir [PF-07321332] tablets and ritonavir tablets).
Who Should Buy? Or Key stakeholders
- Pharmaceutical companies
- Contract manufacturing organizations (CMOs)
- API manufacturers
- Regulatory authorities
- Investors
- Research organizations
- Distributors and wholesalers
- Others
Active Pharmaceutical Ingredient/ API Market Regional Analysis
The active pharmaceutical ingredient/ API market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America is the largest revenue generator, with a market share of 39 %. The United States has the greatest pharmaceutical R&D spending in the world. It is also the most important market for completed dose formulations and bulk pharmaceuticals. The US market runs on free market principles, which aim to establish open trade regulations and prevent anti-competitive behavior. makers worldwide are under substantial cost pressure as a result of the FDA’s major rise in regulatory requirements for API makers in the United States. The FDA has boosted the frequency with which it inspects international producers and organized teams to visit firms in certain countries. The API market in the United States is anticipated to expand significantly over the forecast period, despite pricing pressures and regulatory difficulties.
The European region’s active pharmaceutical ingredient industry is expected to increase significantly. This is attributable to a variety of causes, including increasing research funding and the presence of large market competitors in the region. The expansion of R&D programmers by pharmaceutical and biopharmaceutical businesses is projected to be a significant driver of this increase.
Key Market Segments: Active Pharmaceutical Ingredient/ API Market
Active Pharmaceutical Ingredient/ API Market by Business Mode 2022-2029, (USD Billion) (Kilotons)
- Captive API
- Merchant API
Active Pharmaceutical Ingredient/ API Market by Synthesis Type, 2022-2029, (USD Billion) (Kilotons)
- Synthetic
- Biotech
Active Pharmaceutical Ingredient/ API Market by Type, 2022-2029, (USD Billion) (Kilotons)
- Generic
- Branded
Active Pharmaceutical Ingredient/ API Market by Application, 2022-2029, (USD Billion) (Kilotons)
- Cardiology
- Pulmonology
- Oncology
- Ophthalmology
- Neurology
- Orthopedic
Active Pharmaceutical Ingredient/ API Market by Regions, 2022-2029, (USD Billion) (Kilotons)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the active pharmaceutical ingredient/ API market over the next 7 years?
- Who are the major players in the active pharmaceutical ingredient/ API market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the active pharmaceutical ingredient/ API market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the active pharmaceutical ingredient/ API market?
- What is the current and forecasted size and growth rate of the global active pharmaceutical ingredient/ API market?
- What are the key drivers of growth in the active pharmaceutical ingredient/ API market?
- What are the distribution channels and supply chain dynamics in the active pharmaceutical ingredient/ API market?
- What are the technological advancements and innovations in the active pharmaceutical ingredient/ API market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the active pharmaceutical ingredient/ API market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the active pharmaceutical ingredient/ API market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of active pharmaceutical ingredient/ API in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET OUTLOOK
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY BUSINESS MODE, 2020-2029, (USD BILLION) (KILOTONS)
- CAPTIVE API
- MERCHANT API
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY SYNTHESIS TYPE, 2020-2029, (USD BILLION) (KILOTONS)
- SYNTHETIC
- BIOTECH
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TYPE, 2020-2029, (USD BILLION) (KILOTONS)
- GENERIC
- BRANDED
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY APPLICATION, 2020-2029, (USD BILLION) (KILOTONS)
- CARDIOLOGY
- PULMONOLOGY
- ONCOLOGY
- OPHTHALMOLOGY
- NEUROLOGY
- ORTHOPEDIC
- GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY REGION, 2020-2029, (USD BILLION) (KILOTONS)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCT OFFERED, RECENT DEVELOPMENTS)
10.1. PFIZER INC.
10.2. NOVARTIS INTERNATIONAL AG
10.3. SANOFI S.A.
10.4. MERCK & CO., INC.
10.5. BOEHRINGER INGELHEIM GMBH
10.6. TEVA PHARMACEUTICAL INDUSTRIES LTD.
10.7. ELI LILLY AND COMPANY
10.8. GLAXOSMITHKLINE
10.9. MERCK & CO., INC.
10.10. ABBVIE INC.
10.11. DR. REDDY’S LABORATORIES LTD.
10.12. SUN PHARMACEUTICAL INDUSTRIES LTD.
10.13. AMGEN INC.
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY REGION (USD BILLION) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY REGION (KILOTONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (KILOTONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â US ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (KILOTONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (KILOTONS) 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â Â Â INDIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â Â Â CHINA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â Â Â JAPAN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 131Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 132Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 133Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 134Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 135Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 136Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 137Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 138Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 139Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 140Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 141Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 142Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 143Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 144Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 145Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 146Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 147Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 148Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 149Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 150Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 151Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 152Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 153Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 154Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (KILOTONS) 2020-2029
TABLE 155Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 156Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 157Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 158Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 159Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 160Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 161Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 162Â Â Â Â Â Â Â Â Â Â Â EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 163Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 164Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 165Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 166Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 167Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 168Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 169Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 170Â Â Â Â Â Â Â Â Â Â Â GERMANY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 171Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 172Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 173Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 174Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 175Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 176Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 177Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 178Â Â Â Â Â Â Â Â Â Â Â UK ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 179Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 180Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 181Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 182Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 183Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 184Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 185Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 186Â Â Â Â Â Â Â Â Â Â Â FRANCE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 187Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 188Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 189Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 190Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 191Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 192Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 193Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 194Â Â Â Â Â Â Â Â Â Â Â ITALY ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 195Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 196Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 197Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 198Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 199Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 200Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 201Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 202Â Â Â Â Â Â Â Â Â Â Â SPAIN ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 203Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 204Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 205Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 206Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 207Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 208Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 209Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 210Â Â Â Â Â Â Â Â Â Â Â RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 211Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 212Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 213Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 214Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 215Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 216Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 217Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 218Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 219Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 220Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY COUNTRY (KILOTONS) 2020-2029
TABLE 221Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 222Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 223Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 224Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 225Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 226Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 227Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 228Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 229Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 230Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 231Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 232Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 233Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 234Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 235Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 236Â Â Â Â Â Â Â Â Â Â Â UAE ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 237Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 238Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 239Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 240Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 241Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 242Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 243Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 244Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 245Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 246Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 247Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 248Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 249Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 250Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 251Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 252Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
TABLE 253Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
TABLE 254Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (KILOTONS) 2020-2029
TABLE 255Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
TABLE 256Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (KILOTONS) 2020-2029
TABLE 257Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
TABLE 258Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (KILOTONS) 2020-2029
TABLE 259Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
TABLE 260Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (KILOTONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2020-2029
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY REGION (USD BILLION) 2020-2029
FIGURE 13          PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY TECHNOLOGY (USD BILLION) 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY RESOLUTION COMPONENT (USD BILLION) 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY POWER RATING (USD BILLION) 2021
FIGURE 17Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY CONFIGURATION (USD BILLION) 2021
FIGURE 18Â Â Â Â Â Â Â Â Â Â GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT/ API MARKET BY REGION (USD BILLION) 2021
FIGURE 19Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 20Â Â Â Â Â Â Â Â Â Â PFIZER INC.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â SANOFI S.A.: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â MERCK & CO., INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â ELI LILLY AND COMPANY: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â GLAXOSMITHKLINE: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â MERCK & CO., INC.: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â ABBVIE INC.: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â Â Â Â Â DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â Â Â Â Â Â Â SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
FIGURE 32Â Â Â Â Â Â Â Â Â Â AMGEN INC.: COMPANY SNAPSHOT
FAQ
The global active pharmaceutical ingredient/ API market is projected to reach USD 270.01 billion by 2029 from USD 160.36 billion in 2020, at a CAGR of 6.9 % from 2022 to 2029.
The global active pharmaceutical ingredient/ API market registered a CAGR of 6.9 % from 2022 to 2029.
Growing demand for biopharmaceuticals, strong surge in the demand for cost effective drugs such as generic drugs, and technological advancements in API production are some of the key factors driving the market. v
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.